Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

The Cancer Risk Management Lung Cancer Model

Principal Investigator
Name
Anthony Miller
Degrees
MD, FRCP
Institution
University of Toronto
Position Title
Professor Emeritus
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
NLST-4
Initial CDAS Request Approval
Dec 7, 2012
Title
The Cancer Risk Management Lung Cancer Model
Summary
A microsimulation model using Canadian data has been developed to aid in policy development for and cost-effectiveness of interventions for Cancer Control in Canada. The initial model for lung cancer utilizes Canadian smoking, radon exposure, cost and treatment data. An initial attempt has been made using published data on the NLST to model the impact of low dose computerised tomography (LDCT) screening for lung cancer. We have been able to replicate the results of NLST, but wish to procure additional data to expand the model to encompass annual and or biennial LDCT screening. A particular requirement is to understand how long after the third screen in NLST the incidence of lung cancer returned to a baseline level (inferred from the Chest X-Ray control arm in NLST and published data on Chest X-ray screening in the PLCO trial). We are interested in evaluating different age and gender bands, and also the histologic types. Once the model has been refined, it will be utilized for providing back ground information for lung cancer control, comparing different approaches to reducing lung cancer mortality in Canada.
Aims

To model the effect of low dose computerized (LDCT) screening in Canada on lung cancer mortality

To evaluate the potential cost-effectiveness of annual or biennial continuous LDCT screening on defined high-risk populations.

Collaborators

Dr William Evans, McMaster University, Ontario, Canada
Dr Michael Wolfson, Ottawa University, Ontario, Canada
Mr William Flanagan, Statistics Canada, Ottawa, Ontario
Dr John Goffin, McMaster University, Ontario, Canada
Dr Gina Lockwood, Canadian Partnership against Cancer, Toronto, Ontario, Canada

Related Publications